Sai Parenterals files DRHP with SEBI to raise ₹285 crore via IPO

Sai Parenterals Limited, a Hyderabad-based pharmaceutical manufacturer, has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise ₹285 crore through a public issue. The offer includes a fresh issue of ₹285 crore and an offer-for-sale (OFS) of up to 35 lakh shares. The proceeds will be used for R&D expansion, working capital, debt repayment, and the acquisition of Noumed Pharmaceuticals in Australia. Arihant Capital is acting as the book-running lead manager for the issue.